Monoclonal antibodies against claudin18 for treatment of cancer

Details for Australian Patent Application No. 2012202225 (hide)

Owner Johannes Gutenberg-Universitat Mainz, vertreten durch den Prasidenten Ganymed Pharmaceuticals AG

Inventors Schroder, Anja Kristina; Uherek, Cristoph; Usener, Dirk; Brandenburg, Gunda; Sahin, Ugur; Tureci, Ozlem; Thiel, Philippe; Fritz, Stefan; Geppert, Harald-Gerhard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012202225

Parent 2006316767

Filing date 17 April 2012

Wipo publication date 10 May 2012

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

Event Publications

10 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202225

10 May 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202226-Dissimilar materials sorting process, system and apparatus

2012202224-Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof